*Department of Ophthalmology, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India; †Department of Ophthalmology, Centre for Eye Research Australia, University of Melbourne, Melbourne, Australia; and ‡Department of Ophthalmology, Royal Victorian Eye and Ear Hospital, Melbourne, Australia.
Cornea. 2014 Feb;33(2):114-8. doi: 10.1097/ICO.0000000000000025.
The aim was to study the outcomes and results of therapeutic penetrating keratoplasty (Th PK) at a tertiary eye care hospital in northern India.
In this retrospective interventional study, a cohort of 506 eyes that underwent a Th PK for microbial keratitis was evaluated. Th PK was performed in cases of recalcitrant microbial keratitis with impending perforation (descemetocele formation) or perforation (>3 mm). Medical records were reviewed for demographic details, risk factors, ulcer and perforation size, microbiological investigations, size of donor and recipient beds, postoperative complications, and anatomical and visual outcomes.
Anatomical success was seen in 454 eyes (89.7%). Preoperatively, the corrected distance visual acuity was <3/60 in 495 eyes (97.8%); after performing the Th PK, the corrected distance visual acuity was <3/60 in 249 eyes (49.2%), 3/60 to 6/60 in 182 eyes (35.9%), and >6/60 in 75 eyes (14.8%). Eyes with smaller grafts (<9 mm) had better anatomical and visual outcomes compared with eyes with larger grafts (9-11 mm; P = 0.03 and >11 mm; P = 0.0). A higher success rate was achieved with pure bacterial or fungal organisms rather than with mixed infections. A higher incidence of secondary glaucoma was seen in eyes with perforated ulcers (29.36%; 111/378) than in eyes without perforation (11.71%; 15/128) (P <.01) and in eyes with larger graft sizes (>11 mm and 9-11 mm) than in eyes with smaller graft sizes (<9 mm) (P <0.01).
Th PK has a definitive role in the management of severe and refractory keratitis with a high success in restoring anatomical integrity and providing useful vision. Better outcomes may be achieved with early intervention before perforation or limbal/scleral extension.
本研究旨在探讨在印度北部一家三级眼科医院进行治疗性穿透性角膜移植术(Th PK)的结果。
在这项回顾性干预研究中,评估了 506 例因微生物角膜炎而行 Th PK 的患者。Th PK 适用于治疗有潜在穿孔(出现角膜后弹力层膨出)或穿孔(>3 mm)风险的难治性微生物角膜炎。回顾性分析了患者的人口统计学资料、危险因素、溃疡和穿孔大小、微生物学检查、供体和受体床大小、术后并发症以及解剖和视力结果。
454 只眼(89.7%)达到解剖学成功。术前,495 只眼(97.8%)的矫正视力低于 3/60;行 Th PK 后,249 只眼(49.2%)的矫正视力低于 3/60,182 只眼(35.9%)的矫正视力为 3/60-6/60,75 只眼(14.8%)的矫正视力大于 6/60。与移植片较大(9-11mm;P=0.03 和>11mm;P=0.0)的患者相比,移植片较小(<9mm)的患者具有更好的解剖和视力结果。单纯细菌或真菌感染的成功率高于混合感染。穿孔性溃疡眼(29.36%;111/378)的继发性青光眼发生率高于无穿孔眼(11.71%;15/128)(P<0.01),也高于移植片较大(>11mm 和 9-11mm)的眼(P<0.01)。
Th PK 在治疗严重和难治性角膜炎方面具有明确的作用,能够成功恢复解剖完整性并提供有用的视力。在穿孔或角巩膜缘/巩膜扩展之前进行早期干预可能会获得更好的结果。